Characteristic | Breast cancer patients N (%) | Breast cancer deaths N (%) |
---|---|---|
Total number | 27426 | 1661 (6.1) |
Follow-up time, years, median (range) | 2.57 (0–5.25) | 1.48 (0–4.50) |
Age at diagnosis, years | ||
20-29 | 104 (0.4) | 11 (10.6) |
30-39 | 1042 (3.8) | 73 (7.0) |
40-49 | 4098 (14.9) | 175 (4.3) |
50-59 | 6259 (22.8) | 283 (4.5) |
60-69 | 7869 (28.7) | 329 (4.2) |
70-79 | 4441 (16.2) | 323 (7.3) |
80-89 | 3037 (11.1) | 370 (12.2) |
90≤ | 576 (2.1) | 97 (16.8) |
Median (range) | 62 (20–102) | 68 (21–102) |
Calendar year of diagnosis | ||
2005 | 4267 (15.6) | 451 (10.6) |
2006 | 5769 (21.0) | 477 (8.3) |
2007 | 5721 (20.9) | 359 (6.3) |
2008 | 5829 (21.3) | 250 (4.3) |
2009 | 5840 (21.3) | 124 (2.1) |
Stage | ||
I | 12645 (46.1) | 158 (9.5) |
II | 9715 (35.4) | 670 (40.3) |
III | 1381 (5.0) | 316 (19.0) |
IV | 438 (1.7) | 227 (13.7) |
Missing | 3247 (11.8) | 290 (17.5) |
Severe comorbidity | ||
Disorders associated, with use of ASA* | 2334 (8.5) | 362 (15.5) |
Disorders associated, with decreased use of ASA** | 1116 (4.1) | 182 (16.3) |